Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Shand

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
Clinical Pharmacology and Therapeutics|March 1, 1972
Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol levelC R Cleaveland, D G Shand
Annual Review of Pharmacology and Toxicology|January 1, 1979
Presystemic drug eliminationP A Routledge, D G Shand
Clinical Pharmacokinetics|March 1, 1979
Clinical pharmacokinetics of propranololP A Routledge, D G Shand
Clinical Pharmacology and Therapeutics|December 1, 1975
Plasma concentrations and the time-course of beta blockade due to propranololD G McDevitt, D G Shand
Clinical Pharmacokinetics|March 1, 1979
A re-evaluation of intersubject variation in enzyme induction in manR A Branch, D G Shand
British Medical Journal|September 26, 1970
Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in manD J Coltart, D G Shand
British Journal of Pharmacology|March 1, 1973
Adrenergic control of tendon jerk reflexes in manS J Phillips, A Richens, D G Shand
Clinical Pharmacology and Therapeutics|January 1, 1979
Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for samplingM Wood, D G Shand, A J Wood
British Journal of Pharmacology|November 1, 1970
A method for studying spinal pharmacology in manS J Phillips, A Richens, D G Shand
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1977
Disposition of carbamazepine and its 10,11-epoxide metabolite in the isolated perfused rat liverA Rane, D G Shand, G R Wilkinson
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|March 1, 1972
Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol levelC R Cleaveland, D G Shand
Annual Review of Pharmacology and Toxicology|January 1, 1979
Presystemic drug eliminationP A Routledge, D G Shand
Clinical Pharmacokinetics|March 1, 1979
Clinical pharmacokinetics of propranololP A Routledge, D G Shand
Clinical Pharmacology and Therapeutics|December 1, 1975
Plasma concentrations and the time-course of beta blockade due to propranololD G McDevitt, D G Shand
Clinical Pharmacokinetics|March 1, 1979
A re-evaluation of intersubject variation in enzyme induction in manR A Branch, D G Shand
British Medical Journal|September 26, 1970
Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in manD J Coltart, D G Shand
British Journal of Pharmacology|March 1, 1973
Adrenergic control of tendon jerk reflexes in manS J Phillips, A Richens, D G Shand
Clinical Pharmacology and Therapeutics|January 1, 1979
Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for samplingM Wood, D G Shand, A J Wood
British Journal of Pharmacology|November 1, 1970
A method for studying spinal pharmacology in manS J Phillips, A Richens, D G Shand
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1977
Disposition of carbamazepine and its 10,11-epoxide metabolite in the isolated perfused rat liverA Rane, D G Shand, G R Wilkinson
Pageof 16